Insider Trading Alert - BID, PMD And SEE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 17, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $59.52 to $530,454,750.00.

Highlighted Stocks Traded by Insiders:

Sothebys (BID) - FREE Research Report

Ulmer David, who is SVP Chief Tech & Strat Off at Sothebys, sold 3,000 shares at $46.46 on June 17, 2015. Following this transaction, the SVP Chief Tech & Strat Off owned 20,535 shares meaning that the stake was reduced by 12.75% with the 3,000-share transaction.

The shares most recently traded at $46.82, up $0.36, or 0.77% since the insider transaction. Historical insider transactions for Sothebys go as follows:

  • 4-Week # shares bought: 52,250
  • 4-Week # shares sold: 22,900
  • 12-Week # shares bought: 52,250
  • 12-Week # shares sold: 22,900
  • 24-Week # shares bought: 52,250
  • 24-Week # shares sold: 48,782

The average volume for Sothebys has been 643,800 shares per day over the past 30 days. Sothebys has a market cap of $3.2 billion and is part of the services sector and specialty retail industry. Shares are up 7.97% year-to-date as of the close of trading on Wednesday.

Sotheby's operates as an auctioneer of authenticated fine art, decorative art, and jewelry in the United States, the United Kingdom, China, France, Switzerland, and internationally. It operates through three segments: Agency, Principal, and Finance. The stock currently has a dividend yield of 0.86%. The company has a P/E ratio of 25.3. Currently, there are 3 analysts who rate Sothebys a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BID - FREE

TheStreet Quant Ratings rates Sothebys as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, expanding profit margins, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Sothebys Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Psychemedics (PMD) - FREE Research Report

Schaffer Michael I, who is VP of Laboratory Operations at Psychemedics, sold 2,837 shares at $14.62 on June 17, 2015. Following this transaction, the VP of Laboratory Operations owned 41,965 shares meaning that the stake was reduced by 6.33% with the 2,837-share transaction.

The shares most recently traded at $15.40, up $0.78, or 5.04% since the insider transaction.

The average volume for Psychemedics has been 13,600 shares per day over the past 30 days. Psychemedics has a market cap of $79.4 million and is part of the health care sector and health services industry. Shares are down 2.57% year-to-date as of the close of trading on Wednesday.

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The stock currently has a dividend yield of 4.06%. The company has a P/E ratio of 28.9. Currently, there are no analysts who rate Psychemedics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PMD - FREE

TheStreet Quant Ratings rates Psychemedics as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and premium valuation. Get the full Psychemedics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Sealed Air (SEE) - FREE Research Report

Marino William J, who is Director at Sealed Air, bought 3,213 shares at $49.76 on June 17, 2015. Following this transaction, the Director owned 46,444 shares meaning that the stake was boosted by 7.43% with the 3,213-share transaction.

The shares most recently traded at $51.68, up $1.92, or 3.72% since the insider transaction. Historical insider transactions for Sealed Air go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 19,850
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 19,850
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 39,388

The average volume for Sealed Air has been 1.6 million shares per day over the past 30 days. Sealed Air has a market cap of $10.7 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 19.51% year-to-date as of the close of trading on Wednesday.

Sealed Air Corporation provides food safety and security, facility hygiene, and product protection solutions worldwide. The stock currently has a dividend yield of 1.03%. The company has a P/E ratio of 38.1. Currently, there are 3 analysts who rate Sealed Air a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SEE - FREE

TheStreet Quant Ratings rates Sealed Air as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Sealed Air Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks